amivantamab
janssen,genmab
['chrysalis,(-chrysalis2),(-chrysalis-2),(-chrysalis 2)', 'biomarker']
great data presented by benjamin besse today at 2023 asco. from the chrysalis study the biomarker cohort; chemonaive patients. met + by ihc predict response (3+ staining, 25% more cells). 
Thoracic Oncology; Clinical Associate Professor; Charles E. Schmidt College of Medicine, Florida Atlantic University; Treasurer, FLASCO.